Exocrine Pancreatic Insufficiency (EPI) Market Research | Share, Size, Analysis, Growth Trends, Revenue Projection Till 2030

In-Depth Analysis of the Global Exocrine Pancreatic Insufficiency (EPI) Market: 2024-2030 Forecasts

MarkNtel Advisors has recently released an in-depth study on the Exocrine Pancreatic Insufficiency (EPI) Market, covering historical data, current market trends, marketing strategies, technological advancements, upcoming technologies, emerging opportunities, and technical advancements in the relevant industry.

What are the primary market insights shaping the trajectory of the industry?

The Global Exocrine Pancreatic Insufficiency (EPI) Market size is estimated to grow at a CAGR of around 7.2% during the forecast period, i.e., 2024-30.

Request Free Sample of the Report – https://www.marknteladvisors.com/query/request-sample/exocrine-pancreatic-insufficiency-market.html

Who are the top players in the Exocrine Pancreatic Insufficiency (EPI) Market?

• AbbVie Inc .
• Nestlé
• Digestive Care, Inc.
• Alcresta Therapeutics, Inc.
• Organon Group of Companies
• Vivus LLC
• Others

Global Exocrine Pancreatic Insufficiency (EPI) Market Segmentation:

By Treatment Method

• Pancreatic Exocrine Replacement Therapies (PERT)- Market Size & Forecast 2019-2030, USD Million
• Nutritional Therapy- Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

• Hospital Pharmacies- Market Size & Forecast 2019-2030, USD Million
• Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
• Online Pharmacies- Market Size & Forecast 2019-2030, USD Million

View Full Report [Including Description + TOC] – https://www.marknteladvisors.com/research-library/exocrine-pancreatic-insufficiency-market.html

Regional/ Countries Insight:

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

What are the primary market drivers influencing the growth of Exocrine Pancreatic Insufficiency (EPI) Market?

Escalating Burden of Exocrine Pancreatic Insufficiency – There has been a significant prevalence of exocrine pancreatic insufficiency across the world. This, in turn, has been attributed to the presence of several patients with cystic fibrosis. For instance, the American Lung Association mentioned in 2022 that there are about 70,000 individuals with cystic fibrosis worldwide. Cystic fibrosis is among the major causes behind the development of exocrine pancreatic insufficiency and with a large percentage of individuals with cystic fibrosis, the cases of exocrine pancreatic insufficiency have increased. As a result, the demand for PERT and nutritional therapy for its treatment has surged, accelerating the overall Exocrine Pancreatic Insufficiency Market.

Similarly,

cancer largely associated with causing exocrine pancreatic insufficiency is also on the rise and is expected to drive the Exocrine Pancreatic Insufficiency Market growth. For instance, according to the Global Cancer Observatory, worldwide in 2022 there were about 511 thousand new cases of pancreatic cancer and by 2045 it will increase to 911 thousand. The estimate suggests that a large group of people worldwide are on the verge of getting affected by exocrine pancreatic insufficiency which would further accelerate the demand for different treatment options available for EPI, thereby driving the overall market for Exocrine Pancreatic Insufficiency.

Sent Customized Report Inquiry – https://www.marknteladvisors.com/query/request-customization/exocrine-pancreatic-insufficiency-market.html

Gain a Competitive Edge with Market Research Report

1. The Global Exocrine Pancreatic Insufficiency (EPI) Market Report by MarkNtel Advisors offers a detailed analysis of the market size, growth rate, competitive landscape, and key players, allowing businesses to gain a comprehensive understanding of market dynamics.
2. Businesses can utilize the report to identify emerging opportunities and potential challenges in the market by highlighting current trends and providing future projections.
3. The insights provided in the report enable companies to align their strategies based on market forecasts, ensuring they can stay ahead of the competition and make informed decisions.
4. Apart from market trends and projections, the Global Exocrine Pancreatic Insufficiency (EPI) Market Report assists in assessing and mitigating risks associated with entering or operating in the market
5. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategic approaches to minimize risks and optimize their operations, enhancing their competitive edge in the market.

About Us

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Information:

• Address: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, India
• Call (India): +91 120 4278433
• Call (USA): +1 628 895 8081
• Email: sales@marknteladvisors.com